MX2012010860A - Compensacion residual para un biosensor. - Google Patents
Compensacion residual para un biosensor.Info
- Publication number
- MX2012010860A MX2012010860A MX2012010860A MX2012010860A MX2012010860A MX 2012010860 A MX2012010860 A MX 2012010860A MX 2012010860 A MX2012010860 A MX 2012010860A MX 2012010860 A MX2012010860 A MX 2012010860A MX 2012010860 A MX2012010860 A MX 2012010860A
- Authority
- MX
- Mexico
- Prior art keywords
- function
- residual
- sample
- output signal
- analyte
- Prior art date
Links
- 239000012491 analyte Substances 0.000 claims abstract description 147
- 238000000034 method Methods 0.000 claims abstract description 95
- 238000012360 testing method Methods 0.000 claims description 198
- 238000005534 hematocrit Methods 0.000 claims description 69
- 210000004369 blood Anatomy 0.000 claims description 51
- 239000008280 blood Substances 0.000 claims description 51
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 49
- 239000008103 glucose Substances 0.000 claims description 49
- 230000007717 exclusion Effects 0.000 claims description 48
- 230000004044 response Effects 0.000 claims description 36
- 238000006243 chemical reaction Methods 0.000 claims description 24
- 238000003860 storage Methods 0.000 claims description 22
- 238000002405 diagnostic procedure Methods 0.000 claims description 15
- 238000004891 communication Methods 0.000 claims description 11
- 230000035945 sensitivity Effects 0.000 claims description 10
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 2
- 230000016507 interphase Effects 0.000 claims 2
- 230000006870 function Effects 0.000 abstract description 342
- 238000006479 redox reaction Methods 0.000 abstract description 10
- 238000005303 weighing Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 139
- 238000004458 analytical method Methods 0.000 description 52
- 238000005259 measurement Methods 0.000 description 49
- 238000004519 manufacturing process Methods 0.000 description 29
- 230000003287 optical effect Effects 0.000 description 29
- 238000004092 self-diagnosis Methods 0.000 description 22
- 239000013060 biological fluid Substances 0.000 description 19
- 230000008569 process Effects 0.000 description 18
- 239000004020 conductor Substances 0.000 description 16
- 230000006872 improvement Effects 0.000 description 16
- 230000009467 reduction Effects 0.000 description 10
- 238000006722 reduction reaction Methods 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 230000007613 environmental effect Effects 0.000 description 8
- 230000001105 regulatory effect Effects 0.000 description 8
- 230000005284 excitation Effects 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 230000032683 aging Effects 0.000 description 5
- 239000007795 chemical reaction product Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- 101100364969 Dictyostelium discoideum scai gene Proteins 0.000 description 4
- 101100364971 Mus musculus Scai gene Proteins 0.000 description 4
- 238000004082 amperometric method Methods 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000009897 systematic effect Effects 0.000 description 4
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 229940116269 uric acid Drugs 0.000 description 3
- 238000004832 voltammetry Methods 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002238 attenuated effect Effects 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000003869 coulometry Methods 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000007429 general method Methods 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000004313 potentiometry Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 125000003831 tetrazolyl group Chemical group 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000000840 electrochemical analysis Methods 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000005429 filling process Methods 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000012804 iterative process Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 102220045637 rs587782266 Human genes 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000009131 signaling function Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3274—Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
- G16Z99/00—Subject matter not provided for in other main groups of this subclass
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31617410P | 2010-03-22 | 2010-03-22 | |
| PCT/US2011/029318 WO2011119533A1 (en) | 2010-03-22 | 2011-03-22 | Residual compensation for a biosensor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012010860A true MX2012010860A (es) | 2013-03-05 |
Family
ID=44065188
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012010860A MX2012010860A (es) | 2010-03-22 | 2011-03-22 | Compensacion residual para un biosensor. |
| MX2015008896A MX368104B (es) | 2010-03-22 | 2011-03-22 | Compensacion residual para un biosensor. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015008896A MX368104B (es) | 2010-03-22 | 2011-03-22 | Compensacion residual para un biosensor. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10591436B2 (enExample) |
| EP (1) | EP2550530A1 (enExample) |
| JP (1) | JP6096655B2 (enExample) |
| KR (1) | KR101929057B1 (enExample) |
| CN (1) | CN103003692B (enExample) |
| BR (1) | BR112012023984A2 (enExample) |
| CA (1) | CA2793878C (enExample) |
| MX (2) | MX2012010860A (enExample) |
| RU (1) | RU2568884C2 (enExample) |
| WO (1) | WO2011119533A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2012010860A (es) | 2010-03-22 | 2013-03-05 | Bayer Healthcare Llc | Compensacion residual para un biosensor. |
| BR112012031375A2 (pt) * | 2010-06-07 | 2016-10-25 | Bayer Healthcare Llc | sistema de gerenciamento de enchimento abaixo do necessário para um biosensor |
| CN105308461B (zh) * | 2013-03-14 | 2017-08-15 | 安晟信医疗科技控股公司 | 样品分析物浓度的逐次逼近法 |
| EP3276355B1 (en) * | 2013-03-14 | 2020-05-06 | Ascensia Diabetes Care Holdings AG | Normalized calibration of analyte concentration determinations |
| CN105283765B (zh) | 2013-03-14 | 2018-01-16 | 安晟信医疗科技控股公司 | 分析物浓度测定的系统误差补偿 |
| EP2781919A1 (en) * | 2013-03-19 | 2014-09-24 | Roche Diagniostics GmbH | Method / device for generating a corrected value of an analyte concentration in a sample of a body fluid |
| JP6789246B2 (ja) | 2015-05-15 | 2020-11-25 | アセンシア・ダイアベティス・ケア・ホールディングス・アーゲーＡｓｃｅｎｓｉａ Ｄｉａｂｅｔｅｓ Ｃａｒｅ Ｈｏｌｄｉｎｇｓ ＡＧ | 改善されたバイオセンサシステム検体測定 |
| EP3485265B1 (en) | 2016-07-12 | 2025-03-12 | Ascensia Diabetes Care Holdings AG | Method for electrochemical analysis by use of alternating output signals from two electrodes |
| ES2856174T3 (es) * | 2016-09-07 | 2021-09-27 | Hoffmann La Roche | Procedimientos para someter a prueba sensores electroquímicos basados en enzimas |
| WO2018104835A1 (en) | 2016-12-05 | 2018-06-14 | Ascensia Diabetes Care Holdings Ag | Risk factor monitoring |
| CN109682968B (zh) * | 2018-11-08 | 2022-03-11 | 上海艾瑞德生物科技有限公司 | 一种荧光免疫试条定量检测测试信号温度矫正方法 |
| WO2021108610A1 (en) * | 2019-11-27 | 2021-06-03 | Senseonics, Incorporated | Methods and systems for reducing difference between calculated and measured analyte levels |
| US12478297B2 (en) | 2019-11-27 | 2025-11-25 | Senseonics, Incorporated | Methods and systems for reducing difference between calculated and measured analyte levels |
| CN111812175B (zh) * | 2020-06-30 | 2022-06-14 | 江苏鱼跃医疗设备股份有限公司 | 一种降低红细胞比容干扰的血液检测方法及生物传感器 |
| CN113607801B (zh) * | 2021-08-09 | 2023-09-29 | 湖南国天电子科技有限公司 | 一种多级可控激发电压控制模块延长传感器寿命的方法 |
Family Cites Families (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431004A (en) * | 1981-10-27 | 1984-02-14 | Bessman Samuel P | Implantable glucose sensor |
| US4750496A (en) * | 1987-01-28 | 1988-06-14 | Xienta, Inc. | Method and apparatus for measuring blood glucose concentration |
| SE466157B (sv) * | 1989-04-25 | 1992-01-07 | Migrata Uk Ltd | Saett att bestaemma glukoshalten hos helblod samt engaangskuvett foer detta |
| US5508171A (en) * | 1989-12-15 | 1996-04-16 | Boehringer Mannheim Corporation | Assay method with enzyme electrode system |
| US5243516A (en) * | 1989-12-15 | 1993-09-07 | Boehringer Mannheim Corporation | Biosensing instrument and method |
| FR2701117B1 (fr) * | 1993-02-04 | 1995-03-10 | Asulab Sa | Système de mesures électrochimiques à capteur multizones, et son application au dosage du glucose. |
| US5352351A (en) * | 1993-06-08 | 1994-10-04 | Boehringer Mannheim Corporation | Biosensing meter with fail/safe procedures to prevent erroneous indications |
| US5366609A (en) * | 1993-06-08 | 1994-11-22 | Boehringer Mannheim Corporation | Biosensing meter with pluggable memory key |
| RU2135993C1 (ru) * | 1994-07-12 | 1999-08-27 | Научно-исследовательский институт радиоэлектроники и лазерной техники МГТУ им.Н.Э.Баумана | Устройство для определения концентрации водно-спиртового раствора |
| IE72524B1 (en) | 1994-11-04 | 1997-04-23 | Elan Med Tech | Analyte-controlled liquid delivery device and analyte monitor |
| US6153069A (en) * | 1995-02-09 | 2000-11-28 | Tall Oak Ventures | Apparatus for amperometric Diagnostic analysis |
| US5582697A (en) * | 1995-03-17 | 1996-12-10 | Matsushita Electric Industrial Co., Ltd. | Biosensor, and a method and a device for quantifying a substrate in a sample liquid using the same |
| US5620579A (en) * | 1995-05-05 | 1997-04-15 | Bayer Corporation | Apparatus for reduction of bias in amperometric sensors |
| US5723284A (en) * | 1996-04-01 | 1998-03-03 | Bayer Corporation | Control solution and method for testing the performance of an electrochemical device for determining the concentration of an analyte in blood |
| ATE227844T1 (de) * | 1997-02-06 | 2002-11-15 | Therasense Inc | Kleinvolumiger sensor zur in-vitro bestimmung |
| US6391558B1 (en) * | 1997-03-18 | 2002-05-21 | Andcare, Inc. | Electrochemical detection of nucleic acid sequences |
| US6391645B1 (en) * | 1997-05-12 | 2002-05-21 | Bayer Corporation | Method and apparatus for correcting ambient temperature effect in biosensors |
| US5798031A (en) * | 1997-05-12 | 1998-08-25 | Bayer Corporation | Electrochemical biosensor |
| WO1998058250A2 (en) | 1997-06-16 | 1998-12-23 | Elan Corporation, Plc | Methods of calibrating and testing a sensor for in vivo measurement of an analyte and devices for use in such methods |
| HU222809B1 (hu) * | 1997-10-03 | 2003-10-28 | 77 Elektronika Műszeripari Kft. | Eljárás és készülék kémiai összetevőnek anyagmintából, különösen vér glükóztartalmának vérmintából történő meghatározásához |
| EP1042667B1 (en) * | 1997-12-22 | 2009-06-17 | Roche Diagnostics Operations, Inc. | Meter |
| CA2311487C (en) * | 1998-05-13 | 2004-02-10 | Cygnus, Inc. | Signal processing for measurement of physiological analytes |
| JP4256588B2 (ja) * | 1998-05-20 | 2009-04-22 | アークレイ株式会社 | 統計的手法を用いた電気化学的測定方法および測定装置 |
| US6475372B1 (en) * | 2000-02-02 | 2002-11-05 | Lifescan, Inc. | Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations |
| CA2305922C (en) * | 1999-08-02 | 2005-09-20 | Bayer Corporation | Improved electrochemical sensor design |
| WO2001021827A1 (en) | 1999-09-20 | 2001-03-29 | Roche Diagnostics Corporation | Small volume biosensor for continuous analyte monitoring |
| US6616819B1 (en) * | 1999-11-04 | 2003-09-09 | Therasense, Inc. | Small volume in vitro analyte sensor and methods |
| JP4050434B2 (ja) * | 1999-11-29 | 2008-02-20 | 松下電器産業株式会社 | サンプルの弁別方法 |
| RU2194987C2 (ru) * | 2000-05-26 | 2002-12-20 | Научно-исследовательский институт кардиологии Томского научного центра СО РАМН | Способ количественного определения катехоламинов в моче |
| US7351323B2 (en) * | 2001-01-17 | 2008-04-01 | Arkray, Inc. | Quantitative analyzing method and quantitative analyzer using sensor |
| US6541266B2 (en) * | 2001-02-28 | 2003-04-01 | Home Diagnostics, Inc. | Method for determining concentration of an analyte in a test strip |
| US6562625B2 (en) * | 2001-02-28 | 2003-05-13 | Home Diagnostics, Inc. | Distinguishing test types through spectral analysis |
| AU784254B2 (en) * | 2001-05-21 | 2006-03-02 | Bayer Corporation | Improved electrochemical sensor |
| US6797150B2 (en) * | 2001-10-10 | 2004-09-28 | Lifescan, Inc. | Determination of sample volume adequacy in biosensor devices |
| WO2003034055A1 (en) * | 2001-10-12 | 2003-04-24 | Arkray, Inc. | Concentration measuring method and concentration measuring device |
| US6872298B2 (en) * | 2001-11-20 | 2005-03-29 | Lifescan, Inc. | Determination of sample volume adequacy in biosensor devices |
| CA2419213C (en) * | 2002-03-07 | 2011-06-21 | Bayer Healthcare Llc | Improved electrical sensor |
| US6964871B2 (en) | 2002-04-25 | 2005-11-15 | Home Diagnostics, Inc. | Systems and methods for blood glucose sensing |
| US6946299B2 (en) | 2002-04-25 | 2005-09-20 | Home Diagnostics, Inc. | Systems and methods for blood glucose sensing |
| AU2003234944A1 (en) * | 2002-08-27 | 2004-03-18 | Bayer Healthcare, Llc | Methods of Determining Glucose Concentration in Whole Blood Samples |
| DE60220288T2 (de) * | 2002-11-21 | 2008-01-17 | Lifescan, Inc., Milpitas | Bestimmung der Genauigkeit eines Probevolumens in Biosensoren |
| US7132041B2 (en) * | 2003-02-11 | 2006-11-07 | Bayer Healthcare Llc | Methods of determining the concentration of an analyte in a fluid test sample |
| RU2241985C1 (ru) * | 2003-03-27 | 2004-12-10 | Томский политехнический университет | Способ количественного определения азитромицина дигидрата методом инверсионной вольтамперометрии |
| EP1467206A1 (en) * | 2003-04-08 | 2004-10-13 | Roche Diagnostics GmbH | Biosensor system |
| JP4222896B2 (ja) | 2003-07-25 | 2009-02-12 | テルモ株式会社 | 成分測定装置 |
| US7452457B2 (en) * | 2003-06-20 | 2008-11-18 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using dose sufficiency electrodes |
| US7488601B2 (en) * | 2003-06-20 | 2009-02-10 | Roche Diagnostic Operations, Inc. | System and method for determining an abused sensor during analyte measurement |
| CA2535833C (en) * | 2003-08-21 | 2013-11-26 | Agamatrix, Inc. | Method and apparatus for assay of electrochemical properties |
| JP4449431B2 (ja) | 2003-11-19 | 2010-04-14 | パナソニック株式会社 | 基質濃度の測定方法 |
| JP4814110B2 (ja) | 2004-02-06 | 2011-11-16 | バイエル・ヘルスケア・エルエルシー | 電気化学的バイオセンサ |
| EP1568311A1 (en) * | 2004-02-27 | 2005-08-31 | Hitachi, Ltd. | Blood sugar level measuring apparatus |
| RU2365407C2 (ru) | 2004-03-08 | 2009-08-27 | Шелл Интернэшнл Рисерч Маатсхаппий Б.В. | Распределитель газа для реактора |
| WO2005103669A1 (ja) * | 2004-04-19 | 2005-11-03 | Matsushita Electric Industrial Co., Ltd. | 血液成分の測定方法、それに用いるバイオセンサおよび測定装置 |
| JP5065013B2 (ja) * | 2004-05-14 | 2012-10-31 | バイエル・ヘルスケア・エルエルシー | グルコースアッセイにおいてヘマトクリットの調整を行う方法、およびそのための装置 |
| WO2006042304A1 (en) | 2004-10-12 | 2006-04-20 | Bayer Healthcare Llc | Concentration determination in a diffusion barrier layer |
| GB0501826D0 (en) | 2005-01-28 | 2005-03-09 | Melys Diagnostics Ltd | Apparatus for measurement of analyte concentration |
| RU2453843C2 (ru) * | 2005-04-08 | 2012-06-20 | Байер Хелткэр Ллк | Окисляемые виды соединений в качестве внутреннего стандарта в контрольных растворах для биосенсоров |
| US7517439B2 (en) * | 2005-04-15 | 2009-04-14 | Agamatrix, Inc. | Error detection in analyte measurements based on measurement of system resistance |
| BRPI0613592A2 (pt) | 2005-07-20 | 2011-01-18 | Bayer Healthcare Llc | amperometria conectada por porta |
| CN106970135B (zh) * | 2005-07-20 | 2019-09-06 | 安晟信医疗科技控股公司 | 门控电流分析法 |
| WO2007040913A1 (en) * | 2005-09-30 | 2007-04-12 | Bayer Healthcare Llc | Gated voltammetry |
| ES2791724T3 (es) | 2006-02-27 | 2020-11-05 | Ascensia Diabetes Care Holdings Ag | Medida de analito ajustada en temperatura para sistemas de biosensor |
| US7966859B2 (en) * | 2006-05-03 | 2011-06-28 | Bayer Healthcare Llc | Underfill detection system for a biosensor |
| RU2465812C2 (ru) * | 2006-05-08 | 2012-11-10 | БАЙЕР ХЕЛТКЭА ЭлЭлСи | Система детектирования аномального выходного сигнала для биосенсора |
| EP2031373B1 (en) | 2006-05-16 | 2019-09-25 | ARKRAY, Inc. | Method for automatically identifying a control liquid |
| US7699973B2 (en) | 2006-06-30 | 2010-04-20 | Abbott Diabetes Care Inc. | Rapid analyte measurement assay |
| US7822557B2 (en) * | 2006-10-31 | 2010-10-26 | Abbott Diabetes Care Inc. | Analyte sensors and methods |
| US8658094B2 (en) | 2007-01-29 | 2014-02-25 | Nalco Company | High temperature and pressure oxidation-reduction potential measuring and monitoring device for hot water systems |
| US20080248581A1 (en) * | 2007-04-06 | 2008-10-09 | Bayer Healthcare Llc | Method for performing correction of blood glucose assay bias using blood hemoglobin concentration |
| WO2009015316A1 (en) * | 2007-07-26 | 2009-01-29 | Home Diagnostics, Inc, | System and methods for determination of analyte concentration using time resolved amperometry |
| US8101062B2 (en) * | 2007-07-26 | 2012-01-24 | Nipro Diagnostics, Inc. | System and methods for determination of analyte concentration using time resolved amperometry |
| EP2223104B1 (en) * | 2007-12-10 | 2018-08-29 | Ascensia Diabetes Care Holdings AG | Slope-based compensation |
| WO2010077660A1 (en) | 2008-12-08 | 2010-07-08 | Bayer Healthcare Llc | Biosensor system with signal adjustment |
| US20100143461A1 (en) | 2008-12-08 | 2010-06-10 | Ben-Zion Solomon | Palonosetron formulation |
| BR112012009291A2 (pt) | 2009-11-10 | 2016-05-31 | Bayer Healthcare Llc | sistema de reconhecimento de subenchimento para um biossensor |
| MX2012010860A (es) * | 2010-03-22 | 2013-03-05 | Bayer Healthcare Llc | Compensacion residual para un biosensor. |
| KR102068949B1 (ko) * | 2010-06-07 | 2020-01-21 | 바이엘 헬쓰케어 엘엘씨 | 2차 출력 신호를 포함하는 기울기-기반 보상 |
| EP2758039B1 (en) * | 2011-09-21 | 2018-01-24 | Ascensia Diabetes Care Holdings AG | Biosensor with error compensation |
| CN105283765B (zh) * | 2013-03-14 | 2018-01-16 | 安晟信医疗科技控股公司 | 分析物浓度测定的系统误差补偿 |
| CN105308461B (zh) * | 2013-03-14 | 2017-08-15 | 安晟信医疗科技控股公司 | 样品分析物浓度的逐次逼近法 |
-
2011
- 2011-03-22 MX MX2012010860A patent/MX2012010860A/es active IP Right Grant
- 2011-03-22 MX MX2015008896A patent/MX368104B/es unknown
- 2011-03-22 KR KR1020127027529A patent/KR101929057B1/ko active Active
- 2011-03-22 RU RU2012144625/15A patent/RU2568884C2/ru active
- 2011-03-22 CN CN201180025412.5A patent/CN103003692B/zh active Active
- 2011-03-22 US US13/053,722 patent/US10591436B2/en active Active
- 2011-03-22 EP EP11712389A patent/EP2550530A1/en not_active Ceased
- 2011-03-22 WO PCT/US2011/029318 patent/WO2011119533A1/en not_active Ceased
- 2011-03-22 BR BR112012023984A patent/BR112012023984A2/pt not_active IP Right Cessation
- 2011-03-22 CA CA2793878A patent/CA2793878C/en not_active Expired - Fee Related
- 2011-03-22 JP JP2013501366A patent/JP6096655B2/ja active Active
-
2020
- 2020-02-04 US US16/781,767 patent/US11988626B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20130016311A (ko) | 2013-02-14 |
| KR101929057B1 (ko) | 2018-12-13 |
| RU2568884C2 (ru) | 2015-11-20 |
| MX368104B (es) | 2019-09-19 |
| CA2793878A1 (en) | 2011-09-29 |
| US10591436B2 (en) | 2020-03-17 |
| CA2793878C (en) | 2018-09-11 |
| US11988626B2 (en) | 2024-05-21 |
| JP2013522647A (ja) | 2013-06-13 |
| CN103003692B (zh) | 2015-01-14 |
| JP6096655B2 (ja) | 2017-03-15 |
| RU2012144625A (ru) | 2014-04-27 |
| US20200173952A1 (en) | 2020-06-04 |
| US20110231105A1 (en) | 2011-09-22 |
| WO2011119533A1 (en) | 2011-09-29 |
| EP2550530A1 (en) | 2013-01-30 |
| HK1177260A1 (en) | 2013-08-16 |
| BR112012023984A2 (pt) | 2016-08-02 |
| CN103003692A (zh) | 2013-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11988626B2 (en) | Residual compensation including underfill error | |
| JP5738770B2 (ja) | 信号調整を持つバイオセンサシステム | |
| US10921278B2 (en) | Slope-based compensation including secondary output signals | |
| JP2012511160A5 (enExample) | ||
| US20130071869A1 (en) | Analysis Compensation Including Segmented Signals | |
| JP6305508B2 (ja) | 分析物濃度決定の正規化された較正 | |
| JP2013528289A5 (enExample) | ||
| JP6494813B2 (ja) | 分析物濃度決定のシステム誤差補償 | |
| JP2016517517A5 (enExample) | ||
| HK1177260B (en) | Residual compensation for a biosensor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |